Nelson N. Stone, MD | Authors

UNIVERSITY OF CALIFORNIA, IRVI

843 Health Sciences Drive

Articles

Hormonal Approaches in the Treatment of Bony Metastases

November 01, 1994

Hormonal therapy for prostate cancer designedto reduce testosterone levels has been employed for decades andprovides objective remission rates of 40% to 60% and subjectiveresponse rates of 60% to 85%. Orchiectomy, as